Page 153 - CW E-Magazine (20-8-2024)

Pharmaceuticals Pharmaceuticals

INVESTING IN INFRASTRUCTURE NON-SURGICAL PROCEDURES
Amgen plans to new technology and innovation India’s aesthetic medicine market set to reach $3-bn

centre in Hyderabad by 2029

US biotech major Amgen has an- India’s aesthetic medicine market
nounced plans to open a new techno- is experiencing unprecedented growth,
logy and innovation site in Hyderabad, driven by a confl uence of factors in-
Telangana. cluding rising disposable incomes,
increasing health consciousness, and
The site, to be known as Amgen rapid urbanisation. Industry projections
India, will be located in HITEC City, estimate the market to reach a substan-
a suburb of Hyderabad, occupying six tial $3.02-bn by 2029, which has cre-
fl oors of the RMZ Spire Tower, with a ated fertile ground for innovation and
potential to accommodate up to 3,000 advancements in the fi eld.
people. The site will be operational in
Q4 2024. India’s rapid emergence as a key
player in the global aesthetic medicine
Amgen said the new tech and inno- landscape was highlighted at a recent
vation centre is aimed at accelerating conclave, ‘Aesthetics – Empowering
digital capabilities across the global Confidence’, organised by Allergan
organisation to advance Amgen’s pipe- Mr. Som Chattopadhyay has been this new site in India, a country known Aesthetics. The event brought together
line of medicines. appointed as national executive to lead for its world-class technology and life leading aesthetic practitioners like
Amgen’s expanded presence in India. sciences talent, marks a signifi cant step Dr. Sanjeev Nelogi, Dr. Rashmi Shetty (L to R) Dr. Sanjeev Negolgi, Dr. Rashmi Shetty, Dr. Anjali Ghatge, Dr. Gopinath Kesavan
“Amgen India will initially build forward in our journey to deliver on our and Dr. Anjali Ghatge, to discuss the indicating a more inclusive consumer their healthcare provider wisely, ensure
and accelerate new technology solu- Amgen with revenues of $28.2-bn mission to serve patients,” said Mr. David transformative potential of aesthetic base. they use legitimate products, and not be
tions and digital capabilities at scale in 2023, is one of the world’s leading Reese, Executive Vice President and medical injectables. scared of needles – this is the smallest
that will enhance effi ciencies across biotech companies with nearly 27,000 Chief Technology Officer at Amgen. “India holds immense potential to needle used in medical science.”
the enterprise,” the company said. The employees and has a presence in around ‘Non-surgical procedures outnumbered become a global leader in aesthetic medi-
site will offer roles that strengthen key 100 countries and regions worldwide, “Amgen’s new site in Hyderabad surgical ones’ cine in the coming decades. Research According to Dr. Ghatge aesthetic
areas of Amgen’s business, including including India. underscores the city’s position as a hub The International Society of Aes- reports highlight that procedures that medicine goes beyond treating the
AI, data science, life science and other for innovation and technology,” Telan- thetic Plastic Surgery reported that were once kept secret are now becom- skin; it’s about enhancing psycholo-
additional global capabilities over time, “Amgen has been a leader in biotech- gana Chief Minister Mr. A. Revanth non-surgical procedures outnumbered ing cultural mainstays and we have been gical well-being and making patients
it added. nology for over 40 years and establishing Reddy said welcoming the investment. surgical ones globally in 2020, signal- at the forefront of the conversation. The feel confi dent in their own skin. “Our
ling a growing preference for minimal- pandemic brought a greater focus on innovative treatments include AI-based
ly-invasive options. Botulinum toxin wellness and self-care, which was an facial analysis and body contouring,
remains the most common non-surgical important shift for consumers. We aim electromagnetic muscle stimulation,
procedure for both men and women and to drive growth and innovation in India’s and injectables like dermal fi llers and
across all age groups, with more than aesthetic medicine market to make botulinum toxin. We offer personali-
9-mn procedures performed by plastic aesthetic treatment accessible and zed, tailor-made approaches for each
surgeons worldwide, a 26.1% increase. benefi cial to a wider population,” a spokes- patient, addressing needs from bone to
In second place, hyaluronic acid proce- person of Allergan Aesthetics said. muscle to skin. Each treatment plan is
dures decreased to 4.3-mn. unique and custom-made, ensuring a
“People often hesitate to try some- comfortable and confi dent experience
Women currently represent the pri- thing new, but now aesthetic medicine, for every individual.” Dr. Nelogi noted
mary demographic for aesthetic proce- like lip fi llers, is as simple as picking up that while once it was believed that
dures, constituting 85.7% of the mar- lipstick from the market. These treat- such treatments are for fi lm stars and
ket. However, a growing acceptance of ments bring psychological well-being to celebrities, “now we see an upward
aesthetic treatments among men and people,” said Dr. Shetty while speaking trend in common people choosing the
millennials is reshaping the industry, at the conclave. “People must choose aesthetic route.”

152 Chemical Weekly August 20, 2024 Chemical Weekly August 20, 2024 153

Contents Index to Advertisers Index to Products Advertised